Cited by 662Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement DisordersGambling Behavior and Treatments

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease

Open access

Weintraub, Daniel, Siderowf, Andrew D., Potenza, Marc N., Goveas, Joseph, Morales, Knashawn H., Duda, John E., Moberg, Paul J., Stern, Matthew B.·2006·Archives of Neurology

DOI 10.1001/archneur.63.7.969PMC PMC1761054

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To determine the frequency and correlates of impulse control disorders (ICDs) in Parkinson disease (PD). DESIGN: An unstructured screening interview for ICDs (compulsive gambling, buying, and sexual behavior) followed by a telephone-administered structured interview for screen-positive patients. SETTING: Two university-affiliated movement disorders centers. PARTICIPANTS: A convenience sample of 272 patients with idiopathic PD who were screened for psychiatric complications. MAIN OUTCOME MEASURES: Presence of compulsive gambling, buying, or sexual behavior as assessed by the Minnesota Impulsive Disorders Interview. RESULTS: Eighteen patients (6.6%) with PD met criteria for an ICD at some point during the course of PD, including 11 (4.0%) with an active ICD. Compulsive gambling and compulsive sexual behavior were equally common. In a multivariate model, treatment with a dopamine agonist (P = .01) and a history of ICD symptoms prior to PD onset (P = .02) predicted current ICD. There were no differences between the dopamine agonists in their association with ICDs (P = .21), and daily doses of dopamine agonists were higher in patients with an ICD than in dopamine agonist-treated patients without an ICD (P < .001). CONCLUSIONS: Patients with PD treated with a dopamine agonist should be made aware of the risk of developing an ICD and monitored clinically. Because dopamine agonists are increasingly being used for other indications, future research should assess the dopamine agonist-associated risk for ICDs in other populations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/archneur.63.7.969

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Untitled work
Sheikh (1986) · doi:10.1300/j018v05n01_09 · Cited by 7,236
An algorithm (decision tree) for the management of Parkinson’s disease (2001):
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 724
Compulsive buying: descriptive characteristics and psychiatric comorbidity.
Ga, C., Faber, R., de Zwaan, M., Raymond, N. C., Sm, S., Ekern, Tb, M., Crosby, R. D., Sj, C., & Ed, E. (1994) · PubMed · Cited by 664
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies
Giovannoni, G. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.423 · Cited by 587
Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.noc50009 · Cited by 563

Show all 17 references

Research works printed but not linked: 2

[4]American Psychiatric Association. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000. Diagnostic and Statistical Manual of Mental Disorders. [Google Scholar]
[6]Tyne HL, Medley G, Ghadiali E, Steigner MJ. Gambling in Parkinson’s disease. Movement Disorders. 2004;19(suppl 9):S195. [Google Scholar]

Sorted by citations

Items 501–600 of 661

Impulse Control Disorders
Voon, V. (2014) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-09537-0_4 · Cited by 2
Malattia di Parkinson
Girotti, F., & Fetoni, V. (2009) · Springer eBooks · doi:10.1007/978-88-470-1120-5_27 · Cited by 2
Maladie de Parkinson et violences sexuelles
Baratta, A., Javelot, H., & Weiner, L. (2011) · L information psychiatrique · doi:10.3917/inpsy.8703.0223 · Cited by 2
L’homéostasie hédonique dans la maladie de Parkinson
Azulay, J. (2007) · L Encéphale · doi:10.1016/s0013-7006(07)92914-0 · Cited by 2
Estudio funcional del receptor dopaminérgico D2 en el sistema nervioso central mediante el uso de ratones mutantes inducibles
del Pilar, E. (2012) · Cited by 2
Prevalence of Impulse Control Disorders among Adult Filipino Patients with Idiopathic Parkinson’s Disease seen at Jose R. Reyes Memorial Medical Center
Guzman, J., Yap, A. D., & Go, C. L. (2016) · Journal of Neurological Research And Therapy · doi:10.14302/issn.2470-5020.jnrt-16-1240 · Cited by 2
Impulse Control Disorders in Parkinson’s disease
Erga, A. H. (2020) · Stavanger University Library eBooks · doi:10.31265/usps.39 · Cited by 2
Les troubles du contrôle des impulsions associés au traitement dopaminergique substitutif antiparkinsonien
Depierreux, F., Crémers, J., Skawiniak, E., Parmentier, É., Delvaux, V., & Garraux, G. (2013) · RMLG. Revue médicale de Liège · Cited by 2
Dopamine agonists
Suski, V. R., & Stacy, M. A. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.020 · Cited by 2
Doping for Chess Performance
Golf, S. W. (2015) · Journal of Sports Medicine & Doping Studies · doi:10.4172/2161-0673.1000160 · Cited by 2
“Indeed, this conclusion might well be applicable to recent reports that some PD patients on dopaminergic agonists developed impulsive behaviors such as gambling, compulsive shopping and hypersexuality [178,179].”
Result
L’hypophyse et ses traitements : comment peuvent-ils influer sur le comportement ?
Mouly, C., Borson‐Chazot, F., & Caron, P. J. (2017) · Annales d Endocrinologie · doi:10.1016/s0003-4266(17)30924-1 · Cited by 2
Hypersexuality in Parkinson’s disease
Klinika Neurologii, W. I. M. L., & Kopka, M. (2017) · Aktualności Neurologiczne · doi:10.15557/an.2017.0017 · Cited by 2
ADRs in a Community Hospital – Do These Numbers Look like Yours?; A Gaggle of “Dermatologic” Reactions – TEN, Iodide Mumps, Doxycycline Phototoxicity; Pergolide-Induced Ergotism; Acute Coronary Syndrome Due to Fluorouracil Infusion; Aripiprazole-Induced Acute Dystonic Reaction; Meta-Analysis: Cardiovascular Events and NSAIDs; More on Dopamine Agonists and Impulse Control Disorders
Shuster, J. (2006) · Hospital Pharmacy · doi:10.1310/hpj4109-816 · Cited by 2
Nonmotor Problems in Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50011-5 · Cited by 2
Progression in Parkinson's DiseasePreprint
Irmady, K., & Przedborski, S. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041641 · Cited by 2
Entscheiden bei Morbus Parkinson – eine Übersicht
Sinz, H., Benke, T., Poewe, W. H., & Delazer, M. (2008) · Zeitschrift für Neuropsychologie · doi:10.1024/1016-264x.19.4.235 · Cited by 1
Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease
Ghadery, C., Valli, M., Mihaescu, A. S., Strafella, R., Navalpotro‐Gómez, I., Kim, J., & Strafella, A. P. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.030 · Cited by 1
Impulse control disorders and other non-motor symptoms in Sri Lankan patients with Parkinson’s disease
Herath, H. M. M. T. B., Wijayawardhana, S., Wickramarachchi, U. I., Senanayake, S., Rodrigo, C., & Senanayake, B. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312342 · Cited by 1
Ankle dorsiflexion range of motion is decreased in parkinson’s disease patients with freezing of gait and high l-dopa equivalent daily dose
Paz, T. D. S. R., Imbiriba, L. A., & Corrêa, C. L. (2025) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2025.02.006 · Cited by 1
“Moral Health”: A Crucial Element to Consider Alongside Physical and Mental Health When Evaluating Patients’ Well-Being
Settimo, L. (2025) · Christian bioethics Non-Ecumenical Studies in Medical Morality · doi:10.1093/cb/cbaf023 · Cited by 1
Clinical Approach to Impulse Control–Related Behavioral Disorders in Parkinson's Disease: A Scoping Review
Goh, J. Y., Chan, L. G., Cardoso, F., & Tan, L. C. (2026) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70777 · Cited by 1
Impulsive compulsive behaviours in patients with Parkinson's disease treated with dopamine agonists
Djamshidian, A., & Lees, A. J. (2012) · UCL Discovery (University College London) · Cited by 1
Störungen von Verhalten und Impulskontrolle beim Morbus Parkinson
Katzenschlager, R. (2008) · Nervenheilkunde · doi:10.1055/s-0038-1627134 · Cited by 1
Addiction and Parkinson’s Disease
Witjas, T., Azulay, J., & Eusébio, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_29 · Cited by 1
Drugs that affect autonomic functions or the extrapyramidal system
Schächter, M. (2008) · Side effects of drugs annual · doi:10.1016/s0378-6080(08)00013-5 · Cited by 1
Sexualité et troubles du comportement sexuel dans la maladie de Parkinson
Scheiber-Nogueira, M.-C. (2008) · Revue Neurologique · doi:10.1016/s0035-3787(08)74098-0 · Cited by 1
A2A Adenosine Receptor Binding Parameters in Platelets from Patients Affected by Pathological Gambling
Martini, C., Daniele, S., Picchetti, M., Panighini, A., Carlini, M., Trincavelli, M. L., Cesari, D., Pozzo, E. D., Golia, F., & Dell’Osso, L. (2011) · Neuropsychobiology · doi:10.1159/000321592 · Cited by 1
“Some patients with Parkinson’s disease treated with D 2 dopamine receptor (D 2 DR) agonists have developed symptoms of PG [”
Background
Impulse control and repetitive behaviors in Parkinson's disease — Are there differences in the relation to dopamine agonist treatment?
Somme, J. H., Gómez‐Esteban, J. C., Tijero, B., Berganzo, K., Lezcano, E., & Zarranz, J. J. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.07.004 · Cited by 1
Impulsive Cross-Dressing in Parkinson's Disease Treated With Ropinerole
Maguire, M., & Cowen, Z. (2011) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.23.1.e8 · Cited by 1
An Update on the Management of Juvenile and Young-Onset Parkinson‘s Disease
Mizuno, Y. (2012) · Future Neurology · doi:10.2217/fnl.12.59 · Cited by 1
Stratégies médicamenteuses
Drapier, S., & Vérin, M. (2015) · Elsevier eBooks · doi:10.1016/b978-2-294-74232-3.00013-1 · Cited by 1
ENFERMEDAD DE PARKINSON, PROYECCIONES FUTURAS, DIAGNÓSTICO PRECOZ, TRATAMIENTO TEMPRANO
Gershanik, O. S. (2008) · Revista Médica Clínica Las Condes · Cited by 1
Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease
Papapetropoulos, S. (2008) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)79039-2 · Cited by 1
Expanding the Formal Category of Impulse Control Disorders
Grant, J. E., & Odlaug, B. L. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195389715.013.0024 · Cited by 1
Impulse-Control Disorders
Gould, C. M., & Sanders, K. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50025-1 · Cited by 1
Addictions comportementales dans la maladie de Parkinson
Corvol, J. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31225-7 · Cited by 1
Degenerative Movement Disorders of the Central Nervous System
Qutubuddin, A. A., Chandan, P., & Carne, W. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-62539-5.00045-x · Cited by 1
Retrospective Study of Safety and Effectiveness of Levodopa in Patients with Parkinsonandrsquo;s Disease
Wang, L., & Xu, L. (2021) · Cited by 1
Identification and Management of Impulse Control Disorders Among Individuals with Parkinson’s Disease
Johnson, A. M., Hyson, H. C., & Roland, K. P. (2011) · Scholarship@Western (Western University) · Cited by 1
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Wang, Q., Liu, F., Wang, X., Zhong, L., Cai, B., & Chen, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-70758-z · Cited by 1
Compra compulsiva: revisión bibliométrica de la productividad científica desde 1985 hasta 2020
Valenzuela, P. S., Coria, M. D. C. D., & Sánchez, B. P. (2024) · psicología desde el caribe · doi:10.14482/psdc.40.1.345.741 · Cited by 1
Relationship of Behavioral Addictions to Eating Disorders and Substance Use Disorders
Weintraub, P., Dunn, T. M., & Yager, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-45378-6_18 · Cited by 2
Sexuelle Dysfunktion und Hyper-sexualität bei Morbus Parkinson
Ebersbach, G., & Gandor, F. (2012) · Nervenheilkunde · doi:10.1055/s-0038-1628250 · Cited by 1
“Zur Behandlung der HS hat sich die Beendigung der Behandlung mit Dopaminagonisten als effektiv erwiesen (33, 39, 40, 47, 48).”
Background
Personality Style in Behavioural Disturbances in Parkinson?s Disease
McDonald, K. R. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000251 · Cited by 1
“Other risk factors include: smoking status, male gender, younger age and younger age of disease onset, co-morbid or previous psychiatric symptoms, previous history of substance abuse, family and personal history of substance and behavioural addictions [2,10,16-21].”
Background
Parkinson Symptoms in Dementia with Lewy Bodies
Mizuno, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-55948-1_8 · Cited by 1
DBS Innovations in the Near Future?
Kumar, V., Machado, A. G., Ramirez‐Zamora, A., & Pilitsis, J. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-23693-3_12 · Cited by 1
Variation of Non-Motor Neurological Symptoms of Parkinson’s disease Patients
Momin, A., Islam, M. E. U., Sharmin, F., Hussain, M. E., & Hoque, M. A. (2019) · Journal of National Institute of Neurosciences Bangladesh · doi:10.3329/jninb.v5i2.43016 · Cited by 1
Erectile dysfunction in Parkinson's disease
Veryugina, N. I., Lyashenko, E. A., & Gankina, O. A. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911909251 · Cited by 1
“Так, прием агонистов дофаминовых рецепторов был ассоциирован с компульсивным сексуальным поведением у 2,7% пациентов [40].”
Nonmotor problems in Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00008-1 · Cited by 1
The effect of psychological and medical conditions on sexuality
Rokach, A., & Patel, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819174-3.00006-1 · Cited by 1
The economics, neurobiology and pharmacology of intertemporal choice in humans
Pine, A. (2011) · UCL Discovery (University College London) · Cited by 1
Comorbid impulse control disorder in bipolar disorder: the role of antidepressants.
Kesebir, S. (2012) · PubMed · Cited by 1
An evaluation of the pathways model of problem gambling using the Quinte Longitudinal Dataset
Mader, J. (2017) · Cited by 1
Psychiatric Disorders
Stormezand, G. N., Borra, R., Klein, H. C., van Laar, P. J., Boellaard, R., & Dierckx, R. A. J. O. (2016) · Springer eBooks · doi:10.1007/978-3-319-31614-7_9 · Cited by 1
Editorial Comment: Sexual Dysfunction in Parkinson Disease: A Multicenter Italian Cross-sectional Study on a Still Overlooked Problem
Javaroni, V. (2021) · International braz j urol · doi:10.1590/s1677-5538.ibju.2021.05.02 · Cited by 1
“Weintraub and colleagues (20) reported that 3.”
CDK6 is differentially expressed in the brains of patients with Parkinson’s Disease.Preprint
Mamoor, S. (2020) · doi:10.31219/osf.io/ymker · Cited by 1
ID2 is differentially expressed in the brains of patients with Parkinson’s Disease.Preprint
Mamoor, S. (2020) · doi:10.31219/osf.io/bgrcd · Cited by 1
Parkinson’s Disease
Korenblum, S., Korczyn, A. D., & Gurevich, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00172-1 · Cited by 1
Impact of Deep Brain Stimulation on Addictive Behaviors: A Case Series of Parkinsonian PatientsPreprint
de Chazeron, I., Lambert, C., Houéto, J., Brousse, G., Jaafari, N., Rascol, O., Ory‐Magne, F., Krack, P., Barroche, G., Schwan, R., et al. (2024) · Preprints.org · doi:10.20944/preprints202408.1081.v1 · Cited by 1
Genomic insights into substance use and disinhibitory disordersPreprint
Williams, C. M., Poore, H. E., Londoño-Correa, D., Ning, Y., Courchesne‐Krak, N. S., Choi, M., Tubbs, J. D., Rosenblatt, M., Tanksley, P. T., Alıev, F., et al. (2026) · medRxiv · doi:10.64898/2026.02.09.26344198 · Cited by 3
Advances in Drug Therapy: Alternative Treatments for the Control of Motor Fluctuations and Dyskinesias
Arbelo, J. M., & Zamor, R. M. D. M. (2011) · InTech eBooks · doi:10.5772/19556
“…AD unrelated to any specific (class effect) (Ceravolo et al., 2010) but may also occur at low doses, at lower age, at disease onset (Voon et al., 2006), the existence of affective disorders (Pontone et al., 2006) and a ICD before PD (Weintraub et al., 2006) and the presence of motor complications.”
Background
Neurobiology of Impulse Control Disorders in Parkinson's Disease
Steeves, T. D. L., Miyasaki, J. M., Lang, A. E., & Strafella, A. P. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch20
Overview of the Medical Treatment of the Non‐Motor and Non‐Dopaminergic Features of Parkinson's Disease
Stacy, M. A., & Jankovic, J. J. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch35
Behavioral impulsivity and hallucinations : insights from Parkinson's disease
Ashourian, P. (2011) · DSpace@MIT (Massachusetts Institute of Technology)
Current Approaches to the Management of Parkinson Disease
Martin, W. R. W., & Wieler, M. (2010) · Health care and disease management · doi:10.1002/9783527629480.ch3
Avaliação do transportador dopaminérgico em jogadores patológicos através de imagens de SPECT com TRODAT-1- 99mTc
Guzzo, R. F. G. (2012) · doi:10.11606/d.5.2012.tde-09012013-165536 · Cited by 1
The role of regret and responsibility in decision-making
Nicolle, A. (2010) · UCL Discovery (University College London)
Specific neuropsychiatric disorders
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.011
Self-citation
Drugs that affect autonomic functions or the extrapyramidal system
Schächter, M. (2010) · Side effects of drugs annual · doi:10.1016/s0378-6080(10)32013-7
Verslaafd door en aan dopamine: de Parkinson-patiënt als ‘junk’
Hovestadt, A. (2006) · Neuropraxis · doi:10.1007/bf03079107
“Dopamine speelt een belangrijke rol bij de impulscontrole en motivatie (Czernecki et al., 2002; Weintraub et al., 2006).”
Background
Untersuchung zur Validität verschiedener Depressionsskalen bezüglich der Subsyndromalen Depression bei M. Parkinson
Breternitz, R. (2013) · Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel)
Development of a new assay for evaluation of l-3,4-dihydroxyphenylalanine cytotoxicity in catalase-mutant Escherichia coli
Wang, D.-H., Horita, M., Tsutsui, K., Sano, K., Sauriasari, R., Masuoka, N., Takemura, Y., Takigawa, T., Takaki, J., & Ogino, K. (2008) · Environmental Toxicology and Chemistry · doi:10.1897/07-617.1
“Administration of L-DOPA in the range of 100 to 800 mg daily is a common choice for treatment of patients with Parkinson’s disease [12,13].”
Background
Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy
Generali, J. A. (2006) · Hospital Pharmacy · doi:10.1310/hpj4105-484
Treatments for progressing Parkinson's disease: a clinical case scenario study.
de Noordhout, A. M., Santens, P., Gérard, J., Gonce, M., Jeanjean, A. P., Flamez, A., Pickut, B. A., Zandijcke, M. V., & Pahwa, R. (2009) · PubMed
The neurobiology of impulse control disorders Neurobiologia dos transtornos do controle dos impulsos
Williams, W. A., & Potenza, M. N. (2008)
Self-citation
The role of regret and responsibility in
Nicolle, A. (2010)
Characterisation of dopamine neurons of the murine ventral tegmental area in primary culture and acute dissociations
Johansson, J. (2014) · Tampere University Institutional Repository (Tampere University)
Prevalencia de las complicaciones del tratamiento antiparkinsoniano: revisión sistemática y estimación de proyecciones
Fernández, D., Pérez-Surio, A. F., & del Val, L. J. L. (2015) · Revista de Neurología · doi:10.33588/rn.6103.2014575
“Entre estos 24 artículos se encuentran cinco metaanálisis [12-16], 10 estudios multicéntricos [17-21], de los cuales cinco son ensayos clínicos aleatorizados [22-26], tres ensayos clínicos en uno solo centro [27-29] y seis estudios observacionales [30-35].”
Background
ETHICAL PERSPECTIVES IN NEUROLOGY
Haberfeld, E., & Williams, M. A. (2010) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000368201.81890.34
“167 Continuum Lifelong Learning Neurol 2010;16(1) no evidence suggests that any particular dopamine agonist carries a greater risk of an ICD; rather, studies show a class effect (Voon et al, 2006a; Voon et al, 2006b; Voon et al, 2009; Weintraub, 2009; Weintraub et al, 2006).”
Background
L-DOPA-Induced Disinhibition in Parkinson Disease: More than Agonistic Behavior
Fritsch, T., Hyde, T., & Wallendal, M. S. (2012) · Biological Systems Open Access · doi:10.4172/2329-6577.1000115
“This finding contradicts reports that only dopamine agonist (DA) therapies are implicated in the development of ICDs [3].”
BackgroundResult
Impulsiv-zwanghafte Verhaltensstörungen in einer deutschen Stichprobe ambulant versorgter
Rohde, K., Riedel, O., Lueken, U., Rietzel, S., Fauser, M., Ossig, C., Reichmann, H., Storch, A., Dresden, T., & Neurologie, K. F. (2013)
Seksualiteit bij de ziekte van Parkinson
Lennaerts, H. H., Forkink, A., & Rabsztyn, P. R. I. (2016) · Nursing · doi:10.1007/s41193-016-0018-1
Manifestaciones no motoras en la enfermedad de Parkinson Artículo de revisión
Canales, V. M., Carlos Juri, C., & Métodos, M. Y. (2008)
Clinical and genetic analysis of levodopa induced dyskinesia in patients with Parkinson's disease
Djuric, G. (2013) · doi:10.2298/bg20130626djuric
Non-motor Symptom Management in Parkinson’s Disease
TOLOSA, E. S., Gaig, C., & Acevedo, L. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199609536.003.0011
Etiologic and Phenotypic Similarities between Medication-Induced Syndromes and Courts' Customary Interpretation of Mental Disease in Exculpatory Defenses
Maddux, J. A. (2007) · The Journal of Psychiatry & Law · doi:10.1177/009318530703500203
НАРУШЕНИЯ ИМПУЛЬСНОГО КОНТРОЛЯ ПРИ БОЛЕЗНИ ПАРКИНСОНА. КЛИНИЧЕСКИЕ СЛУЧАИ
Федорова, Н. В., & Никитина, А. В. (2015)
Impulse Control Behavior in Movement Disorders: Focus on Restless Leg Syndrome
Galati, S. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6777-3_17
Sex and Pharmacological Sexual Enhancement
Parisi, T., Pechnick, R. N., & IsHak, W. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-52539-6_26
Degenerative Movement Disorders of the Central Nervous System
Cole, A. M. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47904-2.00045-3
Original Research Reports Impulsive Behavior and Associated Clinical Variables in Parkinson's Disease
Abosch, A., GUPTE, A. A., Eberly, L. E., Tuite, P., NANCE, M. A., & Grant, J. E. (2011)
Macroprolactinoma: Alternatives to Dopamine Agonist Therapy for Treatment of Macroprolactinomas in Patients Who Present with Psychotic Symptoms
Srinivasa, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-90909-7_2
Psychiatric Symptoms Comorbid with Neurological Syndromes
Ross, E., Khan, S. A., & Burhan, A. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-10401-6_11
Tradução e validação para o português de uma escala de avaliação de transtornos de controle de impulso em pacientes com doença de Parkinson no Brasil
de Almeida, B. L. C., Castro, B. M. D. A. E., & Grippe, T. C. (2019) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n1.2018.6411
Benefits of L-dopa in the treatment of early Parkinson's disease
Nissen, T. D., & Grosset, D. G. (2011) · ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
Mesolimbic Dopaminergic Neural Changes in Relation to the Impulsive Compulsive Behaviors in patients with Parkinson's disease
이지영 (2014) · Seoul National University Open Repository (Seoul National University)
Decision-Making and Impulse-Control Disorders in Parkinson's Disease
Yıldırım, E., Altınayar, S., & Çakmur, R. (2020) · Neurological Sciences and Neurophysiology · doi:10.4103/nsn.nsn_12_20
Intimacy, parkinson’s disease and dementia in the time of the coronavirus
Gila, B., Gurevich, T., & Korczyn, A. D. (2020) · Archive of Gerontology and Geriatrics Research · doi:10.17352/aggr.000022
Hypersexuality Due to Adverse Effects of Medicines and Surgical Interventions
Кочарян, Г. С. (2020) · Health of Man · doi:10.30841/2307-5090.2.2020.212914
Impulse Control Disorders associated with Pramipexole/Ropinirole Use in Non-Parkinson’s Disease: A Scoping Review
Jeong, T. H., Suh, S. M., Song, H. J., & Jeon, N. (2020) · Korean Journal of Clinical Pharmacy · doi:10.24304/kjcp.2020.30.4.250

Authors: Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E., Moberg, P. J., & Stern, M. B.
Affiliations: University of Pennsylvania (US)
ORCID: Weintraub, Daniel
Siderowf, Andrew D.
Potenza, Marc N.
Goveas, Joseph
Morales, Knashawn H.
Venue: Archives of Neurology
Publisher: American Medical Association (AMA)
Published: 2006-07-01
Volume: 63
Issue: 7
Pages: 969
ISSN: 0003-9942 (ISSN-L)
DOI: 10.1001/archneur.63.7.969
PMC: PMC1761054
OpenAlex: W2035890213
Cited by: 662
References: 17
Citations by year: 2026: 14 · 2025: 13 · 2024: 12 · 2023: 16 · 2022: 18 · 2021: 18 · 2020: 36 · 2019: 38 · 2018: 23 · 2017: 32 · 2016: 40 · 2015: 26 · 2014: 40 · 2013: 45 · 2012: 40
FWCI: 30.39
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Archives of Neurology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (K23MH067894)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
Keywords: Parkinson's disease, impulse control disorders, dopamine agonists, gambling addiction, compulsive buying, compulsive sexual behavior, psychiatric complications, adverse drug reactions, risk factors, dose-response relationship
MeSH terms: Pramipexole, Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Gambling, Humans, Disruptive, Impulse Control, and Conduct Disorders, Indoles, Male, Middle Aged, Parkinson Disease, Pergolide, Risk Factors, Sexual Behavior, Sexual Dysfunction, Physiological, Thiazoles, Logistic Models, Dopamine Agonists, Benzothiazoles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks